Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Sale | -$10.6M | -55K | -78.62% | $192.16 | 15K | Sep 2, 2021 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Sale | -$1.38M | -7.19K | -48% | $192.67 | 7.78K | Sep 3, 2021 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2021. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.00 to $194.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.88 to $193.41. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |